Isleworth Healthcare Acquisition Corporation (Nasdaq: ISLE)(“Isleworth”), today announced that it has entered into an agreement with Cytovia Holdings, Inc. (“Cytovia”), a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell engineering and multispecific antibodies (the “Termination Agreement”) to terminate its previously announced Merger Agreement with Cytovia
June 30, 2022
· 4 min read